Home › Attention Deficit Hyperactivity Disorder › New York › New York City
Attention Deficit Hyperactivity Disorder clinical trials in New York City, NY
3 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
RecruitingPhase 3
- The Medical Research Network, LLC, New York
An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening
RecruitingPhase 4
- NYU Langone Health, New York
A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.
RecruitingHealthy volunteers welcome
- Icahn School of Medicine at Mount Sinai, New York
About Attention Deficit Hyperactivity Disorder
Does your child have trouble paying attention? This may be a symptom of attention deficit hyperactive disorder (often called ADHD or ADD). Read more.
More about Attention Deficit Hyperactivity Disorder on MedlinePlus
Attention Deficit Hyperactivity Disorder trials in other cities
- Boston, MA10 studies
- Cincinnati, OH8 studies
- Washington, DC7 studies
- Austin, TX6 studies
- Philadelphia, PA6 studies
- Pittsburgh, PA5 studies
- Las Vegas, NV5 studies
- Orlando, FL5 studies
- Los Angeles, CA4 studies
- Durham, NC4 studies
- Jacksonville, FL4 studies
- Irvine, CA4 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.